ArisGlobal Brings LifeSphere Clinical Leadership to Discuss Remote and Onsite Inspection Readiness
LifeSphere Clinical continues to make a substantial industry impact providing ...
LifeSphere Clinical continues to make a substantial industry impact providing ...
ArisGlobal’s LifeSphere sees significant uptake of clinical software adoption in ...
In person attendance, speaking session, and LifeSphere Regulatory demos mark ...
MIAMI, FL - March 18, 2022 - ArisGlobal®, the leading ...
ArisGlobal’s signature R&D Safety suite continues to record substantial global ...
Leading automated drug development technology platform LifeSphere recognized for outstanding ...
ArisGlobal’s industry-leading regulatory software chosen by top pharmaceutical company for ...
LifeSphere product leaders share insight into how an effective IDMP ...
Serving as ArisGlobal’s Board Chairman since 2020, Gordon will assume ...
ArisGlobal and Snowflake's partnership will help life science companies seamlessly ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved